WrinkleNCT05517720
An Exploratory Investigation of a Novel Skincare Regimen
A study testing Aria Trio complete Facial System in people with Wrinkle and Photoaging, run by Trophy Skin at 1 site in United States.
Trial summary
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. Read more about this study
- Who is it for?
- Ages 25 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Wrinkle, Photoaging, Acne
- What is being tested?
- Aria Trio complete Facial System
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 38 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Apr 2022to 1 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
- Must experience early-stage wrinkles that are not treated by over the counter products (e.g. Adapalene/Differin)
- May experience hyperpigmentation and/or dark spots
- In good general health
- Willing to follow the study protocol skincare routine
- Willing and able to share feedback and take skin pictures via the technology portal
- Discontinue use of any alpha-hydroxy acids (AHAs) or over the counter exfoliating, polishing, or peeling topical skincare treatments 1 week before and for the duration of the study.
Who cannot join
- Anyone with a diagnosed skin condition on their face
- Use of prescription medication relevant to the skin
- Undergoing any cosmetic procedures during the study including Botox, laser, or chemical peel treatments
- Use of oral acne treatment (e.g., Accutane)
- Severe chronic conditions, including oncological conditions or psychiatric disorders.
- Is pregnant, attempting pregnancy, or breastfeeding
Trial locations and contacts
1 site in 1 country.
About this study
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.
- Conditions
- Wrinkle, Photoaging, Acne, Skin Inflammation
- Being tested
- Aria Trio complete Facial System
- Keywords
- wrinkles, fine lines, photoaging, sun spots, acne, enlarged pores, skin health
- Medical subject headings
- Acne Vulgaris, Dermatitis, Melanosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Aria Trio complete Facial SystemOther
Renew Serum, Brighten Serum, and Refine Serum.
| Study group | Role | What they receive |
|---|---|---|
| Aria Trio complete Facial System | Experimental | Skincare system targetting wrinkles, pore size, sun spots, and overall skin quality. Receives: Other: Aria Trio complete Facial System |
What is being measured
The primary outcome is the main question the study is designed to answer.
To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles.
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.
Measured: 4 weeks
Secondary outcomes (1)
To determine the effectiveness of the Aria Trio Complete Facial System being able to improve perceptions of wrinkles, pore size, sun spots, and overall skin quality
Participants will be given surveys at three timepoints so that they can assess the effectiveness of the product over the 4-week trial period
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Aug 2022
- Study start13 Apr 2022
- Primary completion1 Jul 2022
- Study completion1 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for WrinkleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- Trophy Skin
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
- Investigators
- Christopher Hill, PhD, Principal investigator, Citruslabs
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05517720
- Sponsor's protocol ID
- 20245
- Status last verified
- Aug 2022
- First submitted
- 24 Aug 2022
- Last updated
- 26 Aug 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Exploratory Investigation of a Novel Skincare Regimen
- ClinicalTrials.gov ID
- NCT05517720
- Acronym / sponsor ID
- 20245
- Conditions
- Wrinkle, Photoaging, Acne, Skin Inflammation
- Keywords
- wrinkles, fine lines, photoaging, sun spots, acne, enlarged pores, skin health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- Trophy SkinIndustry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 13 Apr 2022 (actual)
- Primary completion
- 1 Jul 2022 (actual)
- Study completion
- 1 Jul 2022 (actual)
- First posted
- 26 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Aria Trio complete Facial System | Experimental | Other: Aria Trio complete Facial SystemSkincare system targetting wrinkles, pore size, sun spots, and overall skin quality. |
Who may qualify
- Ages
- 25 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
- Must experience early-stage wrinkles that are not treated by over the counter products (e.g. Adapalene/Differin)
- May experience hyperpigmentation and/or dark spots
- In good general health
- Willing to follow the study protocol skincare routine
Key exclusion criteria (6 listed)
- Anyone with a diagnosed skin condition on their face
- Use of prescription medication relevant to the skin
- Undergoing any cosmetic procedures during the study including Botox, laser, or chemical peel treatments
- Use of oral acne treatment (e.g., Accutane)
- Severe chronic conditions, including oncological conditions or psychiatric disorders.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Aria Trio complete Facial SystemRenew Serum, Brighten Serum, and Refine Serum. | Other | Aria Trio complete Facial System |
Primary outcome
To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles.
Time frame: 4 weeks
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.
1 secondary outcome
To determine the effectiveness of the Aria Trio Complete Facial System being able to improve perceptions of wrinkles, pore size, sun spots, and overall skin quality
Time frame: 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Aug 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Wrinkle
Active, not recruiting
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
Wrinkle, Lax Skin
Not yet recruitingPhase 2
Can TrenibotulinumtoxinE Reverse OnabotulinumtoxinA Effect in Treating Lateral Canthal Lines?
Wrinkles and Rhytides
Active, not recruiting
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
Hair Reduction, Tattoo Removal
Active, not recruiting
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Skin Laxity, Wrinkle
Not yet recruiting
A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Cheek Wrinkles, Midface Contour Deficiencies
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christopher Hill, PhD principal investigator
Citruslabs
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Aria Trio complete Facial System in people with Wrinkle and Photoaging, run by Trophy Skin at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles. (time frame: 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2022.